Mirum Pharmaceuticals (MIRM) Short Interest Ratio & Short Volume $41.51 +0.38 (+0.92%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Mirum Pharmaceuticals Short Interest DataMirum Pharmaceuticals (MIRM) has a short interest of 6.72 million shares. This marks a -3.59% decrease in short interest from the previous month. The short interest ratio (days to cover) is 18.0, indicating that it would take 18.0 days of the average trading volume of 370,240 shares to cover all short positions.Current Short Interest6,720,000 sharesPrevious Short Interest6,970,000 sharesChange Vs. Previous Month-3.59%Dollar Volume Sold Short$310.60 millionShort Interest Ratio18.0 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares48,010,000 sharesPercentage of Shares Shorted14.00%Today's Trading Volume1,185,007 sharesAverage Trading Volume370,240 sharesToday's Volume Vs. Average320% Short Selling Mirum Pharmaceuticals? Sign up to receive the latest short interest report for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMIRM Short Interest Over TimeMIRM Days to Cover Over TimeMIRM Percentage of Float Shorted Over Time Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Mirum Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20246,720,000 shares $310.60 million -3.6%N/A18 $46.22 11/15/20246,970,000 shares $310.17 million +1.8%N/A18.2 $44.50 10/31/20246,850,000 shares $263.45 million -2.1%N/A18.2 $38.46 10/15/20247,000,000 shares $277.97 million -2.2%N/A15.8 $39.71 9/30/20247,160,000 shares $279.24 million +1.6%N/A13.9 $39.00 9/15/20247,050,000 shares $289.90 million -1.0%N/A11.6 $41.12 Get the Latest News and Ratings for MIRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20247,120,000 shares $306.94 million +3.6%N/A9.8 $43.11 8/15/20246,870,000 shares $285.31 million -5.8%N/A8.9 $41.53 7/31/20247,290,000 shares $295.61 million -10.8%N/A9.7 $40.55 7/15/20248,170,000 shares $322.55 million +14.3%N/A11.5 $39.48 6/30/20247,150,000 shares $244.46 million -8.3%N/A11 $34.19 6/15/20247,800,000 shares $202.18 million -12.4%N/A12.8 $25.92 5/31/20248,900,000 shares $213.87 million +1.0%N/A17.5 $24.03 5/15/20248,810,000 shares $220.16 million +3.7%N/A18.5 $24.99 4/30/20248,500,000 shares $213.44 million -0.9%N/A17.4 $25.11 4/15/20248,580,000 shares $205.15 million +5.2%N/A17.2 $23.91 3/31/20248,160,000 shares $204.98 million +0.3%N/A13.9 $25.12 3/15/20248,140,000 shares $217.91 million +6.3%N/A13.5 $26.77 2/29/20247,660,000 shares $219.92 million -1.5%N/A11.9 $28.71 2/15/20247,780,000 shares $225.46 million -0.9%N/A11.9 $28.98 1/31/20247,850,000 shares $207.71 million +8.0%N/A11.6 $26.46 1/15/20247,270,000 shares $198.40 million +0.6%N/A10.8 $27.29 12/31/20237,230,000 shares $213.43 million +4.2%N/A12.1 $29.52 12/15/20236,940,000 shares $242.41 million +12.5%N/A12.3 $34.93 11/30/20236,170,000 shares $197.87 million -3.0%N/A11.2 $32.07 11/15/20236,360,000 shares $193.09 million +4.6%N/A12.2 $30.36 10/31/20236,080,000 shares $166.77 million -2.6%22.6%12.4 $27.43 10/15/20236,240,000 shares $175.47 million +4.9%24.7%12.3 $28.12 9/30/20235,950,000 shares $188.02 million +8.2%23.5%10.2 $31.60 9/15/20235,500,000 shares $180.68 million +8.3%21.8%9.4 $32.85 8/31/20235,080,000 shares $134.26 million +0.6%20.2%9 $26.43 8/15/20235,050,000 shares $129.73 million +24.7%18.7%9.4 $25.69 7/31/20234,050,000 shares $104.33 million +35.0%14.9%7.5 $25.76 7/15/20233,000,000 shares $78.75 million -8.0%11.1%5.7 $26.25 6/30/20233,260,000 shares $84.34 million +10.1%12.1%5.3 $25.87 6/15/20232,960,000 shares $83.15 million +0.7%11.0%5.1 $28.09 5/31/20232,940,000 shares $77.12 million -7.3%11.8%5.6 $26.23 5/15/20233,170,000 shares $82.52 million +1.6%12.7%6.4 $26.03 4/30/20233,120,000 shares $83.77 million +4.4%13.0%6.6 $26.85 4/15/20232,990,000 shares $74.72 million +69.9%12.5%6.3 $24.992025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] 3/31/20231,760,000 shares $42.28 million -10.2%7.2%4.5 $24.02 3/15/20231,960,000 shares $46.31 million +7.1%8.0%6.5 $23.63 2/28/20231,830,000 shares $43.02 million -2.7%7.7%5.7 $23.51 2/15/20231,880,000 shares $42.41 million +14.6%7.9%5.6 $22.56 1/31/20231,640,000 shares $38.51 million +42.6%7.1%4.5 $23.48 1/15/20231,150,000 shares $25.30 million +9.5%4.9%3.2 $22.00 12/30/20221,050,000 shares $20.48 million -13.2%4.5%2.8 $19.50 12/15/20221,210,000 shares $21.62 million -18.8%5.3%3.1 $17.87 11/30/20221,490,000 shares $27.79 million -11.8%6.6%3.7 $18.65 11/15/20221,690,000 shares $33.85 million -8.2%7.4%4.3 $20.03 10/31/20221,840,000 shares $41.49 million -10.2%8.2%4.4 $22.55 10/15/20222,050,000 shares $39.20 million -18.3%9.2%5 $19.12 9/30/20222,510,000 shares $52.74 million +6.4%11.2%6.6 $21.01 9/15/20222,360,000 shares $54.09 million +0.9%10.5%7.1 $22.92 8/31/20222,340,000 shares $58.45 million +8.3%11.4%7.9 $24.98 8/15/20222,160,000 shares $55.58 million +1.9%10.6%7.5 $25.73 7/31/20222,120,000 shares $53.21 million +0.5%11.5%8.1 $25.10 7/15/20222,110,000 shares $50.91 million +5.0%11.7%9.2 $24.13 6/30/20222,010,000 shares $39.11 million +21.8%11.1%8.8 $19.46 6/15/20221,650,000 shares $31.17 million +16.2%9.2%7.3 $18.89 5/31/20221,420,000 shares $33.21 million +67.9%7.9%7.4 $23.39 5/15/2022846,000 shares $20.30 million +13.7%4.7%4.7 $24.00 4/30/2022744,300 shares $17.70 million +14.0%4.1%4.3 $23.78 4/15/2022653,000 shares $17.96 million +19.8%3.6%3.6 $27.50 3/31/2022545,100 shares $12.00 million -27.2%3.2%3 $22.02 3/15/2022748,800 shares $16.21 million +55.7%4.4%4.3 $21.65 2/28/2022480,900 shares $11.40 million +2.7%2.9%2.9 $23.70 2/15/2022468,200 shares $10.28 million -18.1%2.8%2.8 $21.95 1/31/2022571,900 shares $10.89 million +20.3%3.5%3.5 $19.05 1/15/2022475,500 shares $8.91 million +5.2%2.8%3.5 $18.74 12/31/2021452,100 shares $7.21 million -0.5%2.7%3.3 $15.95 12/15/2021454,400 shares $6.65 million +10.3%2.7%2 $14.63 11/30/2021411,800 shares $5.86 million +13.6%2.5%1.8 $14.23 11/15/2021362,600 shares $5.62 million -19.9%2.2%1.6 $15.49 10/29/2021452,400 shares $7.18 million -3.6%2.7%2.2 $15.88 10/15/2021469,300 shares $8.03 million -2.1%3.1%2.3 $17.12 9/30/2021479,200 shares $9.55 million +17.3%3.1%2.6 $19.92 9/15/2021408,400 shares $7.53 million -11.6%2.6%3.9 $18.43 8/31/2021461,800 shares $7.50 million +5.2%3.0%5.6 $16.25 8/13/2021439,200 shares $6.25 million +10.8%2.9%5.4 $14.24 7/30/2021396,400 shares $5.73 million -43.4%2.6%4.6 $14.45 7/15/2021699,800 shares $10.93 million +3.8%4.6%9 $15.62 6/30/2021673,900 shares $11.65 million -10.4%4.4%8.6 $17.29 6/15/2021751,800 shares $13.53 million +5.8%5.0%8.8 $18.00 5/28/2021710,600 shares $11.75 million -4.1%4.7%7.5 $16.54 5/14/2021741,200 shares $12.93 million -1.6%4.9%6.9 $17.45 4/30/2021752,900 shares $14.26 million -2.1%5.0%6.3 $18.94 4/15/2021768,900 shares $14.33 million -1.9%5.1%6.1 $18.64 3/31/2021784,000 shares $14.89 million +9.4%5.3%5.5 $18.99 3/15/2021716,700 shares $14.23 million +6.3%4.9%4.1 $19.862025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] 2/26/2021674,100 shares $12.62 million +5.7%4.7%3.1 $18.72 2/12/2021637,700 shares $13.09 million -0.3%4.5%3.2 $20.53 1/29/2021639,300 shares $11.62 million -35.8%4.5%3.3 $18.18 1/15/2021996,300 shares $18.39 million -2.3%7.0%5.4 $18.46 12/31/20201,020,000 shares $18.56 million +26.6%8.4%6 $18.20 12/15/2020805,800 shares $19.34 million +13.7%6.6%6.1 $24.00 11/30/2020708,700 shares $15.77 million +7.0%6.8%11.3 $22.25 11/15/2020662,600 shares $12.72 million +1.8%6.4%9.9 $19.19 10/30/2020650,900 shares $10.50 million +5.4%6.6%10.3 $16.13 10/15/2020617,700 shares $12.22 million -1.4%6.3%8.7 $19.78 9/30/2020626,400 shares $12.07 million +5.0%6.3%9 $19.27 9/15/2020596,700 shares $12.61 million -1.6%6.0%8.2 $21.14 8/31/2020606,300 shares $15.74 million +4.3%6.1%7.6 $25.96 8/14/2020581,600 shares $14.06 million -4.2%5.9%6.4 $24.17 7/31/2020607,300 shares $13.41 million -6.7%6.1%6.4 $22.08 7/15/2020650,700 shares $12.33 million +2.0%6.5%7.5 $18.95 6/30/2020637,800 shares $12.41 million +17.2%6.4%7.5 $19.46 6/15/2020544,000 shares $9.58 million +0.7%5.4%6.8 $17.61 5/29/2020540,200 shares $9.04 million -0.9%5.4%6.6 $16.74 5/15/2020545,100 shares $9.39 million +1.9%5.5%8.2 $17.23 4/30/2020535,200 shares $9.18 million +3.2%5.1%8.2 $17.16 4/15/2020518,600 shares $7.66 million -1.2%4.9%7 $14.78 3/31/2020525,100 shares $8.09 million -15.0%4.9%4.4 $15.41 3/13/2020617,900 shares $9.11 million -4.3%5.8%9.5 $14.75 2/28/2020645,300 shares $7.03 million +5.7%6.1%1.8 $10.89 2/14/2020610,400 shares $7.88 million +27.1%5.7%1.7 $12.91 1/31/2020480,100 shares $7.94 million +20.1%5.3%1.3 $16.54 1/15/2020399,800 shares $6.87 million +48.7%4.4%1.1 $17.19 12/31/2019268,800 shares $4.71 million +139.4%3.0%0.8 $17.54 MIRM Short Interest - Frequently Asked Questions What is Mirum Pharmaceuticals' current short interest? Short interest is the volume of Mirum Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 6,720,000 shares of MIRM short. Learn More on Mirum Pharmaceuticals' current short interest. What is a good short interest ratio for Mirum Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MIRM shares currently have a short interest ratio of 18.0. Learn More on Mirum Pharmaceuticals's short interest ratio. Which institutional investors are shorting Mirum Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mirum Pharmaceuticals: Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Mirum Pharmaceuticals' short interest increasing or decreasing? Mirum Pharmaceuticals saw a drop in short interest in November. As of November 30th, there was short interest totaling 6,720,000 shares, a drop of 3.6% from the previous total of 6,970,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mirum Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Mirum Pharmaceuticals: Revolution Medicines, Inc. (9.61%), Lantheus Holdings, Inc. (6.73%), Legend Biotech Co. (13.04%), Nuvalent, Inc. (12.26%), Blueprint Medicines Co. (6.60%), Elanco Animal Health Incorporated (3.15%), Cytokinetics, Incorporated (12.35%), TG Therapeutics, Inc. (20.71%), Viking Therapeutics, Inc. (16.22%), BridgeBio Pharma, Inc. (11.52%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Mirum Pharmaceuticals stock? Short selling MIRM is an investing strategy that aims to generate trading profit from Mirum Pharmaceuticals as its price is falling. MIRM shares are trading up $0.38 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mirum Pharmaceuticals? A short squeeze for Mirum Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MIRM, which in turn drives the price of the stock up even further. How often is Mirum Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MIRM, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Revolution Medicines Short Interest Data Lantheus Short Interest Data Legend Biotech Short Interest Data Nuvalent Short Interest Data Blueprint Medicines Short Interest Data Elanco Animal Health Short Interest Data Cytokinetics Short Interest Data TG Therapeutics Short Interest Data Viking Therapeutics Short Interest Data BridgeBio Pharma Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MIRM) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
